文献速递泌尿男性生殖肿瘤

基于活检的前列腺癌Gleason分级自动化深度学习系统:一项诊断研究

Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
PubMed 文献 · Lancet Oncol · 2020-01-08

本研究开发了一种遵循Gleason分级标准的深度学习系统,用于前列腺活检的自动分级,训练集来自Radboud大学医学中心2012至2017年的随机活检样本,采用半自动标注技术。外部测试集上系统与独立参照标准的一致性在观察者间变异范围内。

要点

  • 在观察者实验中系统评分高于专家小组中位数,优于10/15名病理学家。
  • 系统有望辅助病理学家筛查活检、提供分级第二意见及定量体积测量。

核心结论

  • 自动化深度学习系统在前列腺活检Gleason分级上达到与病理学家相似的性能,可能有助于前列腺癌诊断。

研究设计与样本

  • 回顾性诊断研究,开发深度学习系统使用Radboud大学医学中心2012年1月1日至2017年12月31日期间随机抽取的活检样本,共收集5759例活检来自1243例患者。
  • 验证使用独立测试集550例活检,由三位专家泌尿病理学家设定共识参照标准;其中100例用于观察者实验,比较系统、13名病理学家和2名病理学培训生。
  • 外部测试数据集包含886条芯针活检,其中245条来自不同中心并由两名病理学家独立分级。

关键数值与推荐

  • Gleason分级标准为系统开发依据。
  • 临床决策阈值包括良性vs恶性、分级组≥2、分级组≥3。

临床怎么用

  • 系统可能辅助病理学家通过筛查活检、提供分级组第二意见以及呈现体积百分比定量测量。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Gleason score is the strongest correlating predictor of recurrence for prostate cancer, but has substantial inter-observer variability, limiting its usefulness for individual patients. Specialised urological pathologists have greater concordance; however, such expertise is not widely available. Prostate cancer diagnostics could thus benefit from robust, reproducible Gleason grading. We aimed to investigate the potential of deep learning to perform automated Gleason grading of prostate biopsies. METHODS: In this retrospective study, we developed a deep-learning system to grade prostate biopsies following the Gleason grading standard. The system was developed using randomly selected biopsies, sampled by the biopsy Gleason score, from patients at the Radboud University Medical Center (pathology report dated between Jan 1, 2012, and Dec 31, 2017). A semi-automatic labelling technique was used to circumvent the need for manual annotations by pathologists, using pathologists' reports as the reference standard during training. The system was developed to delineate individual glands, assign Gleason growth patterns, and determine the biopsy-level grade. For validation of the method, a consensus reference standard was set by three expert urological pathologists on an independent test set of 550 biopsies. Of these 550, 100 were used in an observer experiment, in which the system, 13 pathologists, and two pathologists in training were compared with respect to the reference standard. The system was also compared to an external test dataset of 886 cores, which contained 245 cores from a different centre that were independently graded by two pathologists. FINDINGS: We collected 5759 biopsies from 1243 patients. The developed system achieved a high agreement with the reference standard (quadratic Cohen's kappa 0·918, 95% CI 0·891-0·941) and scored highly at clinical decision thresholds: benign versus malignant (area under the curve 0·990, 95% CI 0·982-0·996), grade group of 2 or more (0·978, 0·966-0·988), and grade group of 3 or more (0·974, 0·962-0·984). In an observer experiment, the deep-learning system scored higher (kappa 0·854) than the panel (median kappa 0·819), outperforming 10 of 15 pathologist observers. On the external test dataset, the system obtained a high agreement with the reference standard set independently by two pathologists (quadratic Cohen's kappa 0·723 and 0·707) and within inter-observer variability (kappa 0·71). INTERPRETATION: Our automated deep-learning system achieved a performance similar to pathologists for Gleason grading and could potentially contribute to prostate cancer diagnosis. The system could potentially assist pathologists by screening biopsies, providing second opinions on grade group, and presenting quantitative measurements of volume percentages. FUNDING: Dutch Cancer Society.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Bulten W, Pinckaers H, van Boven H, et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 2020. PMID: 31926805. doi:10.1016/S1470-2045(19)30739-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。